YYSkin-resident innate lymphoid cells converge on a pathogenic effector state by Bielecki, P, Riesenfeld, SJ, Hutter, JC, Triglia, ET, Kowalczyk, MS, Ricardo-Gonzalez, RR, Lian, M, Vesely, MCA, Kroehling, L, Xu, H, Slyper, M, Muus, C, Ludwig, LS, Christian, E, Tao, LM, Kedaigle, AJ, Steach, HR, York, AG, Skadow, MH, Yaghoubi, P, Dionne, D, Jarret, A, McGee, HM, Porter, CBM, Licona-Limon, P, Bailis, W, Jackson, R, Gagliani, N, Gasteiger, G, Locksley, RM, Regev, A, Flavell, RA

Get full text

Skin-resident innate lymphoid cells converge on a pathogenic effector state by Bielecki, Piotr, Riesenfeld, Samantha J., Hütter, Jan-Christian, Torlai Triglia, Elena, Kowalczyk, Monika S., Ricardo-Gonzalez, Roberto R., Lian, Mi, Amezcua Vesely, Maria C., Kroehling, Lina, Xu, Hao, Slyper, Michal, Muus, Christoph, Ludwig, Leif S., Christian, Elena, Tao, Liming, Kedaigle, Amanda J., Steach, Holly R., York, Autumn G., Skadow, Mathias H., Yaghoubi, Parastou, Dionne, Danielle, Jarret, Abigail, McGee, Heather M., Porter, Caroline B. M., Licona-Limón, Paula, Bailis, Will, Jackson, Ruaidhrí, Gagliani, Nicola, Gasteiger, Georg, Locksley, Richard M., Regev, Aviv, Flavell, Richard A.

Get full text

Phase I clinical trials of aroA aroD and aroA aroD htrA attenuated S. typhi vaccines; effect of formulation on safety and immunogenicity by Dilts, D.A., Riesenfeld-Örn, I., Fulginiti, J.P., Ekwall, E., Granert, C., Nonenmacher, J., Brey, R.N., Cryz, S.J., Karlsson, K., Bergman, K., Thompson, T., Hu, B., Brückner, A.H., Lindberg, A.A.

Get full text